Shockwave Medical Inc (STU:36M)
€ 308.2 -0.9 (-0.29%) Market Cap: 11.64 Bil Enterprise Value: 11.40 Bil PE Ratio: 78.21 PB Ratio: 16.70 GF Score: 63/100

Shockwave Medical Inc at JPMorgan Healthcare Conference Transcript

Jan 10, 2024 / 03:30PM GMT
Release Date Price: €187.85
Unidentified Analyst

Hi, all welcome. My name is Caroline Browski, and I'm a member here at the JPMorgan Healthcare Investment Banking Group. It is my pleasure to introduce Doug Godshall, President and CEO of Shockwave Medical. Welcome.

Douglas E. Godshall
Shockwave Medical, Inc. - President, CEO & Director

Thanks very much. Thanks, everybody, for joining me -- joining us early at least California time for a little update on Shockwave. I will, of course, be making forward-looking statements. So there will be a quiz on this at the end of today, so please memorize our disclaimers.

At Shockwave, we are on a mission to establish ourselves as the premier med tech growth company by transforming treatment of poorly served patient populations with paradigm-changing technologies.

We have in front of us a $14 billion opportunity. We look to simplify procedures, optimize outcomes and to validate our technologies through clinical evidence generation. So we're really enthusiastic about the future, obviously, and love the opportunity in front of us.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot